Skip to main content
. 2019 Jan 15;11(1):176. doi: 10.3390/nu11010176

Figure 1.

Figure 1

Experimental design (A) and changes in body and brain weights (B) in control, D-galactose (D-gal), ascorbic acid (150 mg/kg; AA), and ascorbic acid (150 mg/kg)-fed D-gal (D-gal + AA) groups (n = 27 per group). 5-bromo-2′-deoxyuridine (BrdU) was intraperitoneally (IP) injected. # p < 0.05, indicating a significant difference between control and D-gal groups. * p < 0.05, indicating a significant difference between D-gal and D-gal + AA groups. Data are presented as means ± SEM. wk: week.